Cyrus Karkaria
Corporate Officer/Principal bei LUPIN LIMITED
Aktive Positionen von Cyrus Karkaria
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
LUPIN LIMITED | Corporate Officer/Principal | 07.10.2011 | - |
Karriereverlauf von Cyrus Karkaria
Ehemalige bekannte Positionen von Cyrus Karkaria
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Corporate Officer/Principal | - | - |
Ausbildung von Cyrus Karkaria
University of Mumbai | Graduate Degree |
University of Maryland | Doctorate Degree |
Harvard Medical School | Graduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Indien | 3 |
Operativ
Corporate Officer/Principal | 2 |
Graduate Degree | 2 |
Doctorate Degree | 1 |
Sektoral
Consumer Services | 4 |
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
LUPIN LIMITED | Health Technology |
Private Unternehmen | 1 |
---|---|
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Health Technology |
- Börse
- Insiders
- Cyrus Karkaria
- Erfahrung